Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (346)

Clear all filters
Clear all filters

Telaglenastat

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)

Teplizumab (Onc Adjacent)

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Tiragolumab

Immunotherapy (Investigational Checkpoint)

Therapeutic Category

Immunotherapy (Investigational Checkpoint)

Oncology Type

Solid Tumour

Drug Class / Mechanism

TIGIT Inhibitor

Toremifene Citrate

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Trastuzumab Rezetecan

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Trebananib

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Tunlametinib

Targeted Therapy (Investigational)

Therapeutic Category

Targeted Therapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

DNA Damage Response Inhibitor

Tusamitamab Ravtansine

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Urelumab

Immunotherapy (Investigational)

Therapeutic Category

Immunotherapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Costimulatory / Bispecific Agent

Utomilumab

Immunotherapy (Investigational)

Therapeutic Category

Immunotherapy (Investigational)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Costimulatory / Bispecific Agent

Vadastuximab Talirine

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent

Vanucizumab

Targeted Therapy (Investigational Antibody / ADC)

Therapeutic Category

Targeted Therapy (Investigational Antibody / ADC)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Investigational Monoclonal / ADC Agent